VOCLOSPORIN IS EFFECTIVE IN ACHIEVING PROTEINURIA TREATMENT TARGETS IN LUPUS NEPHRITIS DEFINED BY EULAR/ERA RECOMMENDATIONS

被引：1
|
作者：
Anders, H. J. [1 ]
Federico, R. [2 ]
Randhawa, S. [2 ]
Leher, H. [2 ]
机构：
[1] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
[2] Aurinia Pharmaceut Inc, Med Affairs, Victoria, BC, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.210
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0285
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [21] Treatment recommendations in children and adolescents with lupus nephritis
    Haffner, D.
    Hoyer, P. F.
    Zimmerhackl, L. B.
    Toenshoff, B.
    Ehrich, J. H. H.
    Gahr, M.
    Mueller-Wiefel, D. E.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (12) : 1175 - +
  • [22] EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association-Immunonephrology Working Group (ERA-IWG) perspective
    Frangou, Eleni
    Bruchfeld, Annette
    Fernandez-Juarez, Gema M.
    Floege, Juergen
    Goumenos, Dimitrios
    Moran, Sarah M.
    Steiger, Stefanie
    Stevens, Kate, I
    Turkmen, Kultigin
    Kronbichler, Andreas
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (05) : 727 - 730
  • [23] THERAPEUTIC TARGETS AND QUALITY INDICATORS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), DEFINED ACCORDING TO THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS: DATA FROM THE "ATTIKON" LUPUS COHORT
    Havatza, K.
    Togia, K.
    Flouda, S.
    Pieta, A.
    Gioti, O.
    Nikolopoulos, D.
    Kapsala, N.
    Ntourou, A.
    Rapsomaniki, P.
    Gerogianni, T.
    Tseronis, D.
    Aggelakos, M.
    Karageorgas, T.
    Katsimpri, P.
    Bertsias, G.
    Thomas, K.
    Boumpas, D.
    Fanouriakis, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 665 - 666
  • [24] Treatment of lupus nephritis: facing the era of immunotherapy
    Aran, A. A.
    Putterman, C.
    PANMINERVA MEDICA, 2008, 50 (03) : 235 - 245
  • [25] EARLY REDUCTIONS IN PROTEINURIA WITH VOCLOSPORIN TREATMENT ACROSS LUPUS NEPHRITIS BIOPSY CLASSES: POOLED DATA FROM THE AURA-LV AND AURORA 1 TRIALS
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I820 - I822
  • [26] Early Reductions in Proteinuria with Voclosporin Treatment Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV and AURORA 1 Trials
    Askanase, Anca
    Hodge, Lucy
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 706 - 708
  • [27] Treatment With Voclosporin and Anifrolumab in a Patient With Lupus Nephritis and Refractory Discoid Lupus Erythematosus: A Case Report and Literature Review
    Karagenova, Ralina
    Vodusek, Ziga
    Krimins, Rebecca
    Krieger, Adam
    Timlin, Homa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [28] Voclosporin Is Effective in Achieving Complete Renal Response Across Lupus Nephritis Biopsy Classes: Pooled Data from the AURA-LV and AURORA 1 Trials
    Askanase, Anca
    Randhawa, Simrat
    Lisk, Laura
    Mina-Osorio, Paola
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3651 - 3653
  • [29] EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany
    Mucke, Johanna
    Aringer, Martin
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2024, 83 (06): : 431 - 438
  • [30] Tacrolimus is an effective treatment for lupus nephritis in pregnancy
    Webster, P.
    Wardle, A.
    Bramham, K.
    Webster, L.
    Nelson-Piercy, C.
    Lightstone, L.
    LUPUS, 2014, 23 (11) : 1192 - 1196
12345